News

Weight loss jabs will not be enough to make “lasting progress” on tackling the obesity epidemic, leading medics have said.
Weight loss injections will not be enough to make “lasting progress” in tackling the obesity epidemic, leading medical ...
Scientists have produced the first detailed characterization of the changes that weight loss causes in human fat tissue by ...
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...
The researchers found health perks directly linked with weight loss through blood test results, including increases in HDL ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...
A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...
The Health Secretary’s 10-year plan includes proposals to bring down the cost of weight-loss drugs so more patients can get ...